Home/ Supplements/ Probiotics/ ProbioMax Sb DF

ProbioMax Sb DF

product on market Capsule XYMOGEN Safety: 90/100
90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Saccharomyces boulardii and Bifidobacterium animalis lactis HN019 are researched for their roles in supporting digestive health and intestinal flora balance. There is moderate to strong evidence supporting the use of these specific probiotic strains for gastrointestinal function. The overall evidence coverage for this specific formulation remains limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for ProbioMax Sb DF
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Saccharomyces boulardii
250 mg
Proprietary Blend
174 mg
Market median: 80.0mg (20 products) 337 studies (A:8, B:183)

Other Ingredients

Hypromellose Gellan Gum Water Hydroxypropyl Cellulose Ascorbyl Palmitate Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take one capsule daily, or as directed by your healthcare professional.

Warnings & Precautions

Consult your healthcare professional prior to use.

Individuals taking medication should discuss potential interactions with their healthcare professional.

Storage: Store in a cool, dry place out of reach from children.

Formulation Notes

Supports gut integrity and function

ProbioMax Sb DF is ideal for individuals seeking a well-rounded supplement to support a healthy balance of intestinal flora, cellular health, and immune health. It features four probiotic strains, including the extensively studied HN019 strain of Bifidobacterium lactis, plus Saccharomyces boulardii (Sb), a non-pathogenic yeast, to further complement healthy gastrointestinal ecology. Gastro-resistant, vegetarian capsules provide an innovative solution for targeted delivery of sensitive ingredients to the small intestine, as they alleviate exposure in a nitrogen-purged blister pack to provide protection from heat, moisture, and oxygen, factors known to compromise probiotic stability.

Formulated to exclude: Wheat, gluten, soy, animal and diary products, fish, shellfish, peanuts, tree nuts, egg, sesame, ingredients derived from genetically modified organisms (GMOs), artificial colors, and artificial sweeteners.

Colony-Forming Unit

Gastro-resistant, vegetarian capsules provide an innovative solution for targeted delivery of sensitive ingredients to the small intestine, as they alleviate exposure in a nitrogen-purged blister pack to provide protection from heat, moisture, and oxygen, factors known to compromise probiotic stability.

Vegetarian Caps

Additional Information

ePV (ePedigree Verification)

Storage: Store in a cool, dry place out of reach from children.

Third-Party Verified GMP Compliant

Scan to Learn More!

Clean Seas turn the tide on plastic Xymogen is committed to reducing the amount of plastics used throughout our business, particularly in the packaging of our products. #CleanSeas

Metadata

Product Details

UPC / SKU7 22537 51251 0
DSLD Entry Date2023-12-14
Product TypeOther Combinations
FormCapsule
BrandXYMOGEN
DSLD ID303832
Data Updated2026-04-11
Research

Research Evidence

691
Research Sources
52
Avg Quality
255
Clinical Trial
205
Meta Analysis
123
Rct
81
Systematic Review
18
Cochrane Review
2
Guideline
2
Regulatory Source
1
Other
1
Narrative Review
1
Openfda Safety
A Probiotics for preventing acute upper respiratory tract infections
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Probiotics for preventing acute upper respiratory tract infections
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Probiotics for maintenance of remission in ulcerative colitis
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Probiotics for induction of remission in ulcerative colitis
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Probiotics for preventing acute upper respiratory tract infections
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Probiotics for treating eczema
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Probiotics for treating acute infectious diarrhoea
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A The Gut Microbiome in Depression and Potential Benefit of Prebiotics, Probiotics and Synbiotics: A Systematic Review of Clinical Trials and Observational Studies
Systematic Review International journal of molecular sciences 2022 PubMed DOI
A Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Probiotics to prevent infantile colic
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
View all evidence for Probiotics →
Compare

Similar Products

View all Probiotics products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.